Drug maker Cipla has acquired Inzpera Healthscience for approximately Rs 111 crore. This strategic move combines Inzpera's paediatric produ...

Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...

Torrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...

Endura and all other associated trademarks would be part of the acquisition. CHL will initiate the distribution and marketing of the Endura...

Founded in 1935 by Hamied’s grandfather in then-colonial Bombay, Cipla made its name globally by pioneering the sale of cheap, generic HIV ...

The deal closure, that involved approvals from the US regulatory agencies, will see Cipla vault its sales from that market to around $400 m...

India Ratings & Research today said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based compan...

Cipla has acquired a portfolio of largely plain vanilla oral solids where its capabilities are already well-established, and hence the acqu...

"Cipla's portfolio is of a commodity generics type; so this will definitely place it in a strong position in terms of product pipeline in t...

The deal has the approval of Brazilian health authority (ANVISA) and other regulatory authorities to import and distribute pharmaceutical p...

While Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...

At 09:35 a.m.; Cipla was trading 0.6 per cent higher at Rs 560.75. It hit a low of Rs 559 and a high of Rs 565.40 in trade today.

As part of its global expansion, Cipla has been active in acquisitions. Last year, it completed the buyout of South African pharma firm, sa...

"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regula...

Cipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,...

Cipla Ltd today said it has received approval from South Africa and Botswana for the $ 512 million takeover offer to acquire Cipla Medpro

Cipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...